(Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced the Omnipod 5 Automated Insulin Delivery System is now ...

New Delhi, Feb. 06, 2025 (GLOBE NEWSWIRE) -- The global insulin pump market valuation is poised to reach US$ 25.40 billion by 2033, with a CAGR of 17.2% during the forecast period from 2025 to 2033.

New Delhi, Feb. 06, 2025 (GLOBE NEWSWIRE) -- The global insulin pump market valuation is poised to reach US$ 25.40 billion by 2033, with a CAGR of 17.2% during the forecast period from 2025 to 2033.

A new survey has found that Type 1 diabetes can affect everyday decisions for nearly a third of those diagnosed ...

However, this is likely a small market, as the majority of diabetic patients do not require intensive insulin management. Moreover, there is competition in this market (Insulet's Omnipod 5 and ...

DiveWire guarantees visibility for your news announcements through instant distribution to MedTech Dive’s audience and its 60,000 newsletter subscribers for 21 days.

Pre-market: 5:35:52 am GMT-5 ...

Shares of Insulet Corp. PODD shed 1.60% to $283.08 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 0.95% to 6,025.99 and ...

Shares of Insulet Corp. PODD rallied 2.23% to $284.70 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.39% to 6,061. ...

It’s a chronic condition in which your body doesn’t use insulin properly. This causes sugar to build up in your blood, leading to other health problems over the long term. The main goal of ...